1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Kohda, D.
Inagaki, F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
31
11928
11939
10.1021/bi00162a036
1445923
Three-dimensional nuclear magnetic resonance structures of mouse epidermal growth factor in acidic and physiological pH solutions.
1992
US
Biochemistry
BICHAW
0033
0006-2960
31
677
Structure of Epidermal Growth Factor Bound to Perdeuterated Dodecylphosphocholine Micelles Determined by Two-Dimensional NMR and Simulated Annealing Calculations
1992
US
Biochemistry
BICHAW
0033
0006-2960
30
4896
Characterization of Ph Titration Shifts for All the Nonlabile Proton Resonances in a Protein by Two-Dimensional NMR: The Case of Mouse Epidermal Growth Factor
1991
JA
J.Biochem.(Tokyo)
JOBIAO
0418
0021-924X
103
741
Tertiary Structure of Mouse Epidermal Growth Factor Determined by Two-Dimensional 1H NMR
1988
AT
Biochem.Int.
BIINDF
0758
0158-5231
16
647
A Comparative 1H NMR Study of Mouse Alpha(1-53) and Beta(2-53) Epidermal Growth Factors
1988
JA
J.Biochem.(Tokyo)
JOBIAO
0418
0021-924X
103
554
Complete Sequence-Specific 1H Nuclear Magnetic Resonance Assignments for Mouse Epidermal Growth Factor
1988
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6050.717
EPIDERMAL GROWTH FACTOR
1
man
polymer
no
no
NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCQTRDLRWWELR
NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCQTRDLRWWELR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
house mouse
Mus
sample
10090
Mus musculus
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1994-01-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1992-03-24
REL
1
BRUNGER
refinement
X-PLOR
ASN
1
n
1
ASN
1
A
SER
2
n
2
SER
2
A
TYR
3
n
3
TYR
3
A
PRO
4
n
4
PRO
4
A
GLY
5
n
5
GLY
5
A
CYS
6
n
6
CYS
6
A
PRO
7
n
7
PRO
7
A
SER
8
n
8
SER
8
A
SER
9
n
9
SER
9
A
TYR
10
n
10
TYR
10
A
ASP
11
n
11
ASP
11
A
GLY
12
n
12
GLY
12
A
TYR
13
n
13
TYR
13
A
CYS
14
n
14
CYS
14
A
LEU
15
n
15
LEU
15
A
ASN
16
n
16
ASN
16
A
GLY
17
n
17
GLY
17
A
GLY
18
n
18
GLY
18
A
VAL
19
n
19
VAL
19
A
CYS
20
n
20
CYS
20
A
MET
21
n
21
MET
21
A
HIS
22
n
22
HIS
22
A
ILE
23
n
23
ILE
23
A
GLU
24
n
24
GLU
24
A
SER
25
n
25
SER
25
A
LEU
26
n
26
LEU
26
A
ASP
27
n
27
ASP
27
A
SER
28
n
28
SER
28
A
TYR
29
n
29
TYR
29
A
THR
30
n
30
THR
30
A
CYS
31
n
31
CYS
31
A
ASN
32
n
32
ASN
32
A
CYS
33
n
33
CYS
33
A
VAL
34
n
34
VAL
34
A
ILE
35
n
35
ILE
35
A
GLY
36
n
36
GLY
36
A
TYR
37
n
37
TYR
37
A
SER
38
n
38
SER
38
A
GLY
39
n
39
GLY
39
A
ASP
40
n
40
ASP
40
A
ARG
41
n
41
ARG
41
A
CYS
42
n
42
CYS
42
A
GLN
43
n
43
GLN
43
A
THR
44
n
44
THR
44
A
ARG
45
n
45
ARG
45
A
ASP
46
n
46
ASP
46
A
LEU
47
n
47
LEU
47
A
ARG
48
n
48
ARG
48
A
TRP
49
n
49
TRP
49
A
TRP
50
n
50
TRP
50
A
GLU
51
n
51
GLU
51
A
LEU
52
n
52
LEU
52
A
ARG
53
n
53
ARG
53
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
TYR
3
A
N
TYR
3
A
O
HIS
22
A
O
HIS
22
A
N
MET
21
A
N
MET
21
A
O
THR
30
A
O
THR
30
A
N
SER
38
A
N
SER
38
A
O
THR
44
A
O
THR
44
1
A
TYR
37
0.087
SIDE CHAIN
1
A
ARG
41
0.317
SIDE CHAIN
1
A
ARG
48
0.309
SIDE CHAIN
1
A
ARG
53
0.211
SIDE CHAIN
1
5.78
0.90
109.00
114.78
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
49
49
49
N
1
7.44
1.10
130.40
137.84
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
49
49
49
N
1
-7.05
1.00
110.10
103.05
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
50
50
50
N
1
6.34
0.90
109.00
115.34
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
50
50
50
N
1
7.27
1.10
130.40
137.67
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
50
50
50
N
1
A
A
CG
ND1
HIS
HIS
22
22
-0.105
0.015
1.369
1.264
N
1
A
A
CG
CD2
TRP
TRP
50
50
-0.103
0.017
1.432
1.329
N
1
A
SER
2
71.42
-8.77
1
A
TYR
3
41.98
95.42
1
A
PRO
7
-37.81
123.07
1
A
SER
9
-47.04
-19.33
1
A
TYR
10
-84.78
-76.55
1
A
ASP
11
30.29
29.97
1
A
ASN
16
34.93
101.92
1
A
SER
25
-44.57
-80.78
1
A
ASP
27
50.56
17.76
1
A
SER
28
-75.46
-167.34
1
A
CYS
33
-64.11
-146.93
1
A
VAL
34
-162.21
-163.20
1
A
ILE
35
-68.05
54.26
1
A
SER
38
-161.20
-160.53
1
A
ASP
40
-46.50
-93.42
1
A
CYS
42
-171.93
32.61
1
A
THR
44
-103.57
79.10
1
A
LEU
47
-62.54
73.03
1
A
ARG
48
-147.20
-93.67
1
A
TRP
49
-32.63
-88.09
1
A
TRP
50
-44.73
-18.25
1
A
GLU
51
47.81
-90.45
1
A
LEU
52
172.61
127.18
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
EPIDERMAL GROWTH FACTOR (EGF) IN PH 2 SOLUTION (NMR, MINIMIZED MEAN STRUCTURE)
THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE STRUCTURES OF MOUSE EPIDERMAL GROWTH FACTOR IN ACIDIC AND PHYSIOLOGICAL PH SOLUTIONS
1
Y
N
disulf
2.019
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
20
A
SG
CYS
20
1_555
disulf
2.016
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
31
A
SG
CYS
31
1_555
disulf
2.016
A
CYS
33
A
SG
CYS
33
1_555
A
CYS
42
A
SG
CYS
42
1_555
EPIDERMAL GROWTH FACTOR
EPIDERMAL GROWTH FACTOR
EGF_MOUSE
UNP
1
1
P01132
MPWGRRPTWLLLAFLLVFLKISILSVTAWQTGNCQPGPLERSERSGTCAGPAPFLVFSQGKSISRIDPDGTNHQQLVVDA
GISADMDIHYKKERLYWVDVERQVLLRVFLNGTGLEKVCNVERKVSGLAIDWIDDEVLWVDQQNGVITVTDMTGKNSRVL
LSSLKHPSNIAVDPIERLMFWSSEVTGSLHRAHLKGVDVKTLLETGGISVLTLDVLDKRLFWVQDSGEGSHAYIHSCDYE
GGSVRLIRHQARHSLSSMAFFGDRIFYSVLKSKAIWIANKHTGKDTVRINLHPSFVTPGKLMVVHPRAQPRTEDAAKDPD
PELLKQRGRPCRFGLCERDPKSHSSACAEGYTLSRDRKYCEDVNECATQNHGCTLGCENTPGSYHCTCPTGFVLLPDGKQ
CHELVSCPGNVSKCSHGCVLTSDGPRCICPAGSVLGRDGKTCTGCSSPDNGGCSQICLPLRPGSWECDCFPGYDLQSDRK
SCAASGPQPLLLFANSQDIRHMHFDGTDYKVLLSRQMGMVFALDYDPVESKIYFAQTALKWIERANMDGSQRERLITEGV
DTLEGLALDWIGRRIYWTDSGKSVVGGSDLSGKHHRIIIQERISRPRGIAVHPRARRLFWTDVGMSPRIESASLQGSDRV
LIASSNLLEPSGITIDYLTDTLYWCDTKRSVIEMANLDGSKRRRLIQNDVGHPFSLAVFEDHLWVSDWAIPSVIRVNKRT
GQNRVRLQGSMLKPSSLVVVHPLAKPGADPCLYRNGGCEHICQESLGTARCLCREGFVKAWDGKMCLPQDYPILSGENAD
LSKEVTSLSNSTQAEVPDDDGTESSTLVAEIMVSGMNYEDDCGPGGCGSHARCVSDGETAECQCLKGFARDGNLCSDIDE
CVLARSDCPSTSSRCINTEGGYVCRCSEGYEGDGISCFDIDECQRGAHNCAENAACTNTEGGYNCTCAGRPSSPGRSCPD
STAPSLLGEDGHHLDRNSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCQTRDLRWWELRHAGYGQKHDIM
VVAVCMVALVLLLLLGMWGTYYYRTRKQLSNPPKNPCDEPSGSVSSSGPDSSSGAAVASCPQPWFVVLEKHQDPKNGSLP
ADGTNGAVVDAGLSPSLQLGSVHLTSWRQKPHIDGMGTGQSCWIPPSSDRGPQEIEGNSHLPSYRPVGPEKLHSLQSANG
SCHERAPDLPRQTEPVK
977
1029
1EPG
1
53
P01132
A
1
1
53
3
2
anti-parallel
anti-parallel
anti-parallel
A
SER
2
A
SER
2
A
PRO
4
A
PRO
4
A
VAL
19
A
VAL
19
A
ILE
23
A
ILE
23
A
SER
28
A
SER
28
A
ASN
32
A
ASN
32
A
TYR
37
A
TYR
37
A
SER
38
A
SER
38
A
THR
44
A
THR
44
A
ARG
45
A
ARG
45
1
P 1